Replimune (REPL) Current Assets (2018 - 2026)

Replimune has reported Current Assets for 9 years, with the latest figure at $279.1 million in Q1 2026.

• Quarterly Current Assets fell 43.71% year-over-year to $279.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $279.1 million (down 43.71% YoY) and the FY2026 annual result came in at $279.1 million, down 43.71% from the prior year.
• Current Assets was little changed at $279.1 million in Q1 2026 per REPL's latest filing, from $280.4 million in the prior quarter.
• Over five years, Current Assets peaked at $624.0 million in Q4 2022 and troughed at $279.1 million in Q1 2026.
• A 5-year average of $449.8 million and a median of $442.6 million in 2024 frame the typical range for Current Assets.
• The sharpest annual moves came in 2023 and 2025: Current Assets jumped 46.69% in 2023, then sank 48.8% in 2025.
• Over 5 years, Current Assets stood at $624.0 million in 2022, then declined by 23.21% to $479.2 million in 2023, then rose by 14.28% to $547.6 million in 2024, then tumbled by 48.8% to $280.4 million in 2025, then declined by 0.44% to $279.1 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $279.1 million, $280.4 million, and $333.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.